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An increased incidence of obesity is registered worldwide, and its association with insulin 
resistance and type 2 diabetes is closely related with increased morbidity and mortality 
for cardiovascular diseases. A major clinical problem in the management of obesity is the 
non-adherence or low adherence of patients to a hypocaloric dietetic restriction. In this 
study, we evaluated in obese mice the effects of shifting from high-calorie foods to nor-
mal diet on insulin sensitivity. Male C57BL/6JOlaHsd mice (n = 20) were fed with high fat 
diet (HFD) for a 24-week period. Afterward, body weight, energy, and food intake were 
measured in all animals, together with parameters of insulin sensitivity by homeostatic 
model assessment of insulin resistance and plasma glucose levels in response to insulin 
administration. Moreover, in half of these mice, Glut4 mRNA levels were measured in 
muscle at the end of the high fat treatment, whereas the rest of the animals (n = 10) were 
shifted to normocaloric diet (NCD) for 10 weeks, after which the same analyses were 
carried out. A significant reduction of body weight was found after the transition from 
high to normal fat diet, and this decrease correlated well with an improvement in insulin 
sensitivity. In fact, we found a reduction in serum insulin levels and the recovery of insulin 
responsiveness in terms of glucose disposal measured by insulin tolerance test and 
Glut4 mRNA and protein expression. These results indicate that obesity-related insulin 
resistance may be rescued by shifting from HFD to NCD.
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inTrODUcTiOn
Modern lifestyle is often characterized by sedentary activities and overeating. As a consequence, 
in the last decades, this has been responsible for the increased incidence and prevalence of obesity 
and obesity-induced comorbidities, such as insulin resistance and metabolic syndrome (1, 2) that 
may contribute to type 2 diabetes mellitus (T2DM) and cardiovascular disease (3). Several studies 
have demonstrated that a healthy lifestyle can lead to weight loss and improve insulin sensitivity 
(4–7). In this regard, a crucial role is played by the nutrient composition of the diet, both in terms 
of total caloric intake and the variety of its components, with particular attention to the different 
types of fatty acids (8, 9). Unfortunately, most of anti-obesity interventions are often limited by 
the difficulty to maintain a low-calorie dietary regimen, especially when long-term treatments are 
required (10, 11). Thus, few anti-obesity programs have been found to be helpful.
FigUre 1 | study design. A schematic representation of the study protocol 
and experimental plan is shown.
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To date, several animal models have been used to evaluate the 
effects of various dietetic regimens on body weight and meta-
bolic parameters. A validated experimental model is represented 
by mice fed with a high fat diet (HFD), which develop obesity, 
insulin resistance, and dyslipidemia (8–13).
In the present study, we evaluated the effects of the transition 
from HFD to normocaloric diet (NCD) (regular food with no 
additive agents or nutraceutical compounds) on body weight and 
insulin responsiveness in C57BL/6JOlaHsd mice, a strain of mice 
genetically prone to develop obesity and insulin resistance (14).
MaTerials anD MeThODs
animals and study Design
Five-week-old male C57BL/6JOlaHsd mice (n = 20), NCD and 
HFD, were purchased from Harlan Laboratories S.r.l (Udine, 
Italy). Mice were housed in individual cages and maintained on 
12-h light/dark cycle at 21 ± 1°C and 50 ± 5% humidity with 
free access to water and food ad libitum. Animals were fed with 
HFD containing 60.3% kcal fat, 21.3% kcal carbohydrate, and 
18.4% kcal protein (HFD group) for 24 weeks. After this period, 
10 mice were euthanized by cervical dislocation and the other 
10 were fed with NCD only (Teklad Global 18% kcal fat, 58% 
kcal carbohydrate, and 24% kcal protein) (NCD group) for the 
subsequent 10 weeks. A schematic representation of the study 
design is shown in Figure 1. Body weight, girth waist, and food 
intake were recorded at weekly interval for all animals (15). Liver, 
skeletal muscle, and abdominal fat were excised, weighted, and 
stored in liquid nitrogen. This study was performed following the 
Italian (D.M. 116/92) and ECC regulations (O.J. of E.C.L 358/1 
12/18/1986), in accordance with the guide for the care and use of 
laboratory animals and approved by the local ethical committee.
Biochemical analysis
Blood samples were collected after 12 h of fasting. Serum was sep-
arated by centrifugation at 1700 g for 10 min at room temperature 
and stored at −20°C, until use. Total cholesterol and triglycerides 
were measured using commercial reagents (Siemens Healthcare 
Diagnostics, Milano, Italy) and an automated biochemistry ana-
lyzer (Dimension EXL, Siemens Healthcare Diagnostics). Insulin 
levels were measured using ELISA kit (Rat/Mouse Insulin ELISA 
Kit, EMD Millipore Corporation, Darmstadt, Germany), accord-
ing to the manufacturers’ instructions.
insulin Tolerance Test
Insulin tolerance test (ITT) was performed in both HFD and 
NCD groups, as previously described (16). Animals were fasted 
for 12  h, weighed, and injected intraperitoneally with insulin 
(1 U/kg body weight Regular®, Novorapid, Novonordisk, Roma, 
Italy). Blood glucose levels were measured after 0, 15, 30, 60, and 
90  min using an automatic glucometer (Glucocard, Menarini 
Diagnostics, Firenze, Italy).
expression of glucose Transporter Type 4
Total RNA was isolated from quadriceps skeletal muscle using 
TRIzol reagent (Life Technologies, Monza, Italy), following the 
manufacturer’s recommended protocol and quantified with a 
NanoDrop Spectrophotometer (Thermo Fisher Scientific, Inc., 
Waltham, MA, USA). RNA levels were normalized against 18S 
ribosomal RNA in each sample, and cDNAs were synthesized 
from 1 μg of total RNA using the High Capacity cDNA Reverse 
Transcription Kit (Life Technologies). Primers for mouse Glut4 
and ribosomal protein S9 (RPS9) were designed according to 
sequences from the GenBank database. Relative quantification was 
made using a real-time thermocycler (Eppendorf Mastercycler ep 
realplex, Milano, Italy). In a 20-μl final volume, 1 μl of cDNA solu-
tion was mixed with SYBR Green RealMasterMix (Eppendorf) 
and 0.2 μM of each sense and antisense primers. SYBR Green 
fluorescence was measured, and relative quantification was made 
against either RPS9 or Gapdh cDNAs, used as internal standards. 
All PCR reactions were carried out in triplicates. Glut4 protein 
expression was measured in quadriceps muscle from six to eight 
mice of each group, using a rabbit anti-Glut4 polyclonal antibody 
as previously described (17).
statistical analysis
Results are expressed as mean ± SD. The independent t-test was 
used to evaluate intergroup differences. All statistical analyses 
were performed using GraphPad Prism version 5.0 statistical 
software (GraphPad Software Inc., San Diego, CA, USA). p values 
lower than 0.05 were considered statistically significant.
resUlTs
effects of normocaloric Diet on Body 
Weight and Biochemical Parameters
Twenty mice were fed with HFD (HFD group) for 24 weeks, reach-
ing a weight of approximately 43 g, with fasting plasma glucose 
levels between 90.5 and 117.7 mg/dL, which were consistent with 
a condition of impaired fasting glucose. After the 24-week period, 
half of the mice were fed with NCD for the following 10 weeks 
(NCD group). A significant decrease of body weight was observed 
in the NCD group compared to the HFD group (27%, p < 0.001), 
TaBle 1 | Weight and waist in hFD and ncD mice.
hFD ncD p value
Liver (g) 1.24 ± 1.09 1.09 ± 0.09 <0.05
White adipose (g) 1.54 ± 0.31 1.29 ± 0.08 <0.05
Epididymis (g) 0.60 ± 0.16 0.33 ± 0.08 <0.01
Girth waist (cm) 10.55 ± 0.42 9.54 ± 0.17 <0.01
Values are expressed as mean ± SD.
FigUre 2 | effects on body weight, food, and energy intake in mice fed with high fat diet (hFD) for 24 weeks and with normocaloric diet (ncD) for 
other 10 weeks. A significant reduction of body weight and energy intake was observed in NCD mice (a,B), whereas no significant difference was detected in food 
intake (c). Body weight over the time is shown in the inset. Values are expressed as mean ± SD. *p < 0.001.
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as a result of the decrease in energy intake due to the less caloric 
supply derived from the NCD rather than the different food 
intake (Figure 2). In the NCD group, we also observed a decrease 
in liver size, fat depots, and girth waist (Table 1). Moreover, shift-
ing to NCD resulted in a significant decrease in plasma glucose 
levels (p < 0.05) and serum insulin levels (p < 0.01), as well as 
triglycerides (p < 0.05) and total cholesterol (p < 0.05) (Figure 3).
effects on insulin sensitivity
Next, we evaluated the effects of NCD on insulin sensitiv-
ity. ITT performed in mice before and after NCD showed a 
better response to insulin in terms of changes in blood glucose 
 concentrations in the NCD group than in the HFD group. 
In fact, the glucose-lowering effect of exogenous insulin was 
FigUre 3 | Biochemical parameters. Blood samples were collected as indicated in Section “Materials and Methods.” After 10 weeks of feeding with a 
normocaloric diet (NCD), mice showed a significant reduction of plasma glucose levels and serum insulin levels, as well as a reduction in both triglycerides and total 
cholesterol when compared to the HFD. Values are expressed as mean ± SD. *p < 0.05.
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enhanced in NCD mice during ITT and was reduced in HFD 
mice (Figure 4). From a mechanistic point of view, the improve-
ment in insulin sensitivity in mice in response to NCD was 
dependent, at least in part, on an increase in Glut4 expression 
induced in skeletal muscle following the transition from HFD 
to NCD. To show such a molecular link between restoration 
of insulin sensitivity and NCD, total RNA was extracted from 
skeletal muscle of animals before and after shifting to NCD, after 
insulin stimulation, and Glut4 mRNA and protein levels were 
measured. As shown in Figure 5, both insulin-stimulated Glut4 
mRNA and protein expression were significantly increased in 
skeletal muscle of NCD mice as compared with that of HFD 
mice (p < 0.05).
DiscUssiOn
Obesity is a chronic disorder that can cause other health prob-
lems, such as diabetes, hypertension, hepatic steatosis, obstruc-
tive sleep apnea, and atherosclerosis (18). The association of 
obesity with T2DM is well established, due to the negative 
influence of excessive body fat on peripheral insulin action and 
hepatic function, leading to insulin resistance (19). Treatment 
of obesity includes hypocaloric diet, exercise, and lifestyle 
modifications, with dietary manipulation still representing the 
first-line therapeutic approach for this common disorder (20, 
21). However, it is still debated which is the more appropriated 
dietetic regimen to obtain a weight loss, which may be at the 
same time rapid, well tolerated, and sustainable for a long period 
of time. Although the importance of calorie restriction in this 
condition is well recognized, also for the positive psychological 
benefit for the patient and the family, there is no doubt that 
a major problem in treating obesity is still represented by the 
relatively low level of adherence of affected subjects to low/very 
low-calorie diets (22–24). Thus, many dietary strategies have 
been proposed to overcome such obstacles, but the results are 
not satisfactory enough in most of obese patients (25, 26). In 
these individuals, we hypothesized that shifting to normoca-
loric balanced diet, formulated to avoid excess fat, rather than 
hypocaloric diet  –  which would obtain a better compliance 
especially in view of long-term treatment – might be sufficient, 
in addition to physical exercise and lifestyle change, to get 
more satisfactory results in terms of weight loss and conse-
quent improvement in obesity-related insulin resistance. This 
hypothesis is well supported by the present finding in our mouse 
model of obesity and obesity-induced insulin resistance. In fact, 
shifting from HFD to NCD for 10 weeks, caused a significant 
reduction of body weight mainly due to the reduction of vis-
ceral fat, together with the overall reduction of triglycerides, 
total cholesterol, and, most importantly, restoration of insulin 
sensitivity, as reflected by the decline in fasting insulin levels. A 
similar approach treating obese mice with NCD has also been 
FigUre 5 | expression of glut4. Glut4 mRNA levels were measured by 
qRT-PCR in skeletal muscle from HFD and NCD mice, after insulin 
stimulation. Results are the mean ± SD for six animals per group. *p < 0.05 
versus HFD mice. A representative Western blot (WB) of Glut4 in quadriceps 
muscle from six to eight mice of each group is shown in duplicate in the 
autoradiogram. Gapdh, control of protein loading.
FigUre 4 | insulin sensitivity. HFD and NCD mice fasted for 12 h were injected intraperitoneally with insulin (1 U/kg). Blood glucose levels were measured with a 
glucometer, as reported in Section “Materials and Methods.” Values are expressed as mean ± SD. *p < 0.05.
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used in a few other studies where, however, some nutraceutical 
compounds or other ingredients were added to regular food 
(27–30). This is slightly different than what we did in our study, 
in which NCD itself, without any additive agent, was able to 
improve insulin sensitivity and Glut4 expression.
Glut4 is the major insulin-dependent glucose transporter in 
muscle. Abnormalities at this level are a hallmark of peripheral 
insulin resistance (31). In the present study, the improvement 
in insulin sensitivity associated with increased Glut4 mRNA 
 expression in NCD mice provides a possible mechanistic expla-
nation as to how the normal calorie diet can improve insulin 
responsiveness and supports the hypothesis that rescue from 
insulin resistance and diabetes can be reached without the adop-
tion of a low-calorie diet. If confirmed in obese humans, such 
an approach, in association with adequate and individualized 
physical exercise programs, might be able to contribute to coun-
teract the long-term failure of the current therapeutic approaches 
adopted in these individuals, and this would confirm further the 
appropriateness of mouse models for studying human obesity. 
However, on the other hand, it is also known that marked inter-
species differences exist between human and mouse with respect 
to behavioral control of food uptake, tissue energy disposal and 
storage, weight, and weight loss, which emphasize the influence 
of non-genetic environmental factors and genetic modifiers in 
determining the phenotypic variations observed in humans and 
animal models of obesity. Thus, caution is required in general-
izing these findings. As a limitation of the present work, the fact 
is that mice of different ages were compared in our study.
In conclusion, numerous anti-obesity initiatives have been 
adopted up to now, which include lifestyle changes, drug treat-
ments, and surgery. However, because of the limited efficacy 
and the occurrence of adverse events in affected treated patients, 
alternative and complementary therapies for weight loss have 
been investigated, including acupuncture, dietary supplements, 
etc. Our findings in the current work provide valuable informa-
tion about the efficacy of shifting to NCD in restoring weight and 
insulin sensitivity in HFD-induced obese mice. Similar studies in 
obese humans would reveal whether this strategy, probably better 
accepted by patients, may be successful in correcting weight gain 
and obesity-related insulin resistance.
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